10% Calcium ChlorideInjection, USP

For intravenous use only

A HYPERTONIC SOLUTION IN A 10 ML SINGLE-DOSE VIAL FOR PROMPT INTRAVENOUS INJECTION.

CAUTION: This solution must not be injected intramuscularly or subcutaneously. Administer only by slow injection (not to exceed 1 mL/minute).

Sterile, nonpyrogenic
Preservative-free
Vial closure is not made with natural rubber latex

	Pack NDC#	Strength	Supplied as	Shelf pack	Vial opening size	Product info	Availability
	Strength: 1 Gram/10 mL (100 mg/mL) Supplied As: 10 mL Single-dose vial NDC#: 0517-6710-10	0517-6710-10	1 Gram/10 mL (100 mg/mL)	10 mL Single-dose vial	10	13 mm	Product Label Full Prescribing Information Safety Data Sheet	In-Stock Shipping Weekly
Shelf Pack 10 Availability In-Stock Shipping Weekly Product Label Full Prescribing Information Safety Data Sheet Wholesaler Numbers ABC/SAP 10185539 Cardinal 5427174 McKesson 3774833 Case Information Unit of Sale NDC 0517-6710-10 Order Size 10 Case Size 28 Case Per Tier 60 View our list of Authorized Distributors Receive Availability Emails

View Our Sales and Return Policy

Contact Us

Report an Adverse Event Report a Product Quality Complaint Request Medical Information Request a Grant Investigator-Initiated Study Request a Certificate of Analysis Expanded Access Policy

P: 800-645-1706
(8:00am–6pm Monday - Thursday and Friday 8:00am–4pm Eastern Time)
P: 800-734-9236
F: 610-650-0170

Adverse Drug Events (ADEs) may be reported to the FDA:
Phone: 1-800-FDA-1088
Web: www.fda.gov/medwatch
P: 888-354-4859
P: 888-354-4855
(9am–5pm Eastern Time, Monday - Friday)

For drug information outside of normal business hours that cannot wait until the next day, please call:

P: 877-845-6371
American Regent, Inc.
5 Ramsey Road
Shirley, NY 11967

P: 631-924-4000
F: 631-924-1731

Find a Distributor

By clicking Submit, you confirm that you accept our Privacy Policy and that you agree to your personal contact information being used to contact you and added to our database. If at any time you wish your personal information to be removed from the American Regent database, please submit a message request to corpcommunications@americanregent.com.

CONTRAINDICATIONS Calcium chloride is contraindicated for cardiac resuscitation in the presence of ventricular fibrillation or in patients with the risk of existing digitalis toxicity. Calcium chloride is not recommended in the treatment of asystole and electromechanical dissociation. WARNINGS 10% calcium chloride injection is irritating to veins and must not be injected into tissues since severe necrosis and sloughing may occur. Great care should be taken to avoid extravasation or accidental injection into perivascular tissues. WARNING: This product contains aluminum, which may be toxic. Aluminum may reach toxic levels with prolonged parenteral administration if kidney function is impaired. Premature neonates are particularly at risk because their kidneys are immature and they require large amounts of calcium and phosphate solutions, which contain aluminum. PRECAUTIONS Because of its additive effect, calcium should be administered very cautiously to a patient who is digitalized or who is taking effective doses of digitalis or digitalis-like preparations. It is particularly important to prevent a high concentration of calcium from reaching the heart because of the danger of cardiac syncope. Pediatric Use: Safety and effectiveness are based on similar clinical conditions in children and adults. Pregnancy: Calcium chloride should be given to a pregnant woman only if clearly needed. Geriatric Use: In general, dosing for a geriatric patient should be cautious. ADVERSE REACTIONS Rapid injection may cause the patient to complain of tingling sensations, a calcium taste, a sense of oppression, or “heat wave.” Injections of calcium chloride are accompanied by peripheral vasodilatation as well as a local “burning” sensation and there may be a moderate fall in blood pressure. OVERDOSAGE Too rapid an injection may produce a lowering of blood pressure and cardiac syncope. INDICATIONS AND USAGE 10% calcium chloride injection is indicated for the treatment of hypocalcemia in those conditions requiring a prompt increase in plasma calcium levels. For additional safety information, please see Full Prescribing Information. You are encouraged to report Adverse Drug Events to American Regent Inc. at 1-800-734-9236 or to the FDA by visiting www.fda.gov/MedWatch or calling 1-800-FDA-1088.

_{REF-0662 07/2017}